Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDirecta Plus Regulatory News (DCTA)

Share Price Information for Directa Plus (DCTA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 2.00 (12.50%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 17.00
DCTA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

21 Jan 2021 07:00

RNS Number : 3887M
Directa Plus PLC
21 January 2021
 

21 January 2021

 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION (596/2014) WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. UPON THE PUBLICATION OF THE ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

Directa Plus plc

("Directa Plus" or the "Company")

 

Resignation of Chief Financial Officer

 

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, announces that Marco Ferrari, Chief Financial Officer, has tendered his resignation from the Company in order to pursue another business opportunity.

 

Marco will step down from the Board and leave the Company at the end of March 2021. In the interim, he will continue to run, with his team, the finance function of Directa Plus to ensure an orderly handover. In particular, Marco will oversee the preparation of the accounts for the year to 31 December 2020, which are expected to be substantially complete by the time of his departure and announced in April 2021. The Company has already begun the search for a replacement and is confident of being able to recruit a high-quality replacement. Further announcements will be made in due course.

 

Giulio Cesareo, Founder and CEO of Directa Plus, said: "Although I am very sorry to see Marco leave, I recognise that other opportunities to add experience and new challenges can be hard to resist. On behalf of the Board, I would like to thank Marco for his hard work during his time with Directa Plus and wish him well for the future."

 

Marco Ferrari, CFO of Directa Plus, added: "I will miss the Directa Plus family. I have learned a great deal at this company and my thanks are due to all of my colleagues for making such a rewarding working environment for this stage of my career."

 

This announcement has been approved by Giulio Cesareo, Chief Executive, on behalf of the Company.

 

For further information please visit www.directa-plus.com or contact:

 

Directa Plus plc

+39 02 36714458

Giulio Cesareo, CEO

 

Marco Ferrari, CFO

 

 

 

Cenkos Securities plc (Nominated Adviser and Joint Broker)

+44 131 220 6939

Neil McDonald

Pete Lynch

 

 

 

N+1 Singer (Joint Broker)

+44 20 7496 3069

Rick Thompson

Phil Davies

 

 

 

Tavistock (Financial PR and IR)

+44 20 7920 3150

Simon Hudson

Edward Lee

 

 

About Directa Plus

Our focus is principally on the two sectors in which we have strong commercial advantage through developed and launched products and a technological lead: environmental (based on our Grafysorber® product) and textiles (based on our G+® products). In addition, we will continue to pursue opportunities in elastomers and composites (including tyres and asphalt), also using our G+® products. All our products are hypoallergenic, non-toxic and sustainably produced.

 

-ends-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFFFELLVIIFIL
Date   Source Headline
23rd Mar 20207:00 amRNSCovid-19 Update
13th Mar 20207:00 amRNSTrading Update
12th Feb 20207:00 amRNSEco certification of graphene printing technology
3rd Feb 20207:00 amRNSAward of Environmental services contract
27th Jan 20207:00 amRNSEU Grant for Eco-friendly G+ Printing Technology
20th Jan 20207:00 amRNSR&D Agreement with Comerio Ercole
9th Dec 20197:00 amRNSAward of Environmental Services Contract
26th Nov 20197:00 amRNSCompletion of Acquisition
8th Nov 20197:00 amRNSUK road trial of graphene enhanced asphalt
25th Oct 20195:46 pmRNSHolding(s) in Company
25th Oct 20199:00 amRNSHolding(s) in Company
23rd Oct 20195:20 pmRNSHolding(s) in Company
18th Oct 201911:36 amRNSResult of Open Offer, and GM, Issue of Equity
30th Sep 20192:21 pmRNSAcquisition, Placing and Open Offer
30th Sep 20192:21 pmRNSHalf-year Report
10th Sep 20197:00 amRNSNew Textile Membrane Patent Granted
6th Aug 20198:29 amRNSHolding(s) in Company
29th Jul 20197:00 amRNSAward of Oil Decontamination and Recovery Contract
22nd Jul 20197:00 amRNSHolding(s) in Company
4th Jul 20197:00 amRNSUS Patent Grant for Liquid G+
27th Jun 20197:00 amRNSGrant of US Patent
26th Jun 20199:47 amRNSHolding(s) in Company
18th Jun 20191:36 pmRNSResult of AGM
18th Jun 20197:00 amRNSAGM Statement
17th Jun 20197:00 amRNSHolding(s) in Company
28th May 20197:00 amRNSDirector/PDMR Shareholding
23rd May 20197:00 amRNSNew patent grants
23rd May 20197:00 amRNSPosting of Annual Report and Notice of AGM
7th May 20197:00 amRNSCo-operation agreement with Alfredo Grassi S.p.A.
17th Apr 20197:00 amRNSFinal Results for the Year to 31 December 2018
1st Apr 20197:00 amRNSSuccessful First Road Surface Trial Results
4th Mar 20197:00 amRNS3 Year Exclusive Agreement with Loro Piana
6th Feb 20197:00 amRNSUS National Graphene Association Appointment
31st Jan 20194:41 pmRNSHolding(s) in Company
31st Jan 20199:05 amRNSSecond Price Monitoring Extn
31st Jan 20199:00 amRNSPrice Monitoring Extension
30th Jan 20193:45 pmRNSHolding(s) in Company
30th Jan 201911:00 amRNSHolding(s) in Company
30th Jan 201911:00 amRNSHolding(s) in Company
30th Jan 201911:00 amRNSHolding(s) in Company
8th Jan 201911:58 amRNSResult of General Meeting and Total Voting Rights
7th Jan 20191:00 pmRNSResults of Open Offer
13th Dec 20187:00 amRNSAnnouncement of Open Offer
12th Dec 20183:30 pmRNSResults of Placing
12th Dec 201811:30 amRNSProposed Placing to raise a minimum of £3 million
5th Dec 20187:00 amRNSDirecta Plus to present at Denim Première Vision
29th Nov 20187:00 amRNSCollaboration Agreement with Ambienthesis S.p.A.
23rd Nov 20184:00 pmRNSDirecta Plus to present at Mello London
23rd Nov 20187:00 amRNSEnvironmental Sale and Participation in Trial
22nd Nov 20187:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.